Study of severe alcoholic hepatitis patients before early liver transplant
Part of Digestive system, Mental health clinical trials.
This study follows people with severe alcoholic hepatitis who are being considered for an early liver transplant before they’ve been sober for 6 months. It aims to better understand this group’s situation and ethics/safety as early transplantation plans are made.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be listed for liver transplantation at Johns Hopkins Hospital (JHH).
- If you have severe alcoholic hepatitis, you have not been sober for at least 6 months when you are waitlisted.
- If you are sober for at least 6 months before waitlisting, you usually do not qualify for the severe alcoholic hepatitis group.
- This study compares people in an alcoholic liver disease transplant group with different sobriety timelines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
This study compares patterns of liver inflammation and the liver’s healing ability in people with alcohol-related liver disease, using blood tests and (in most cases) a liver tissue sample. It may help doctors better understand what is happening in the liver and how it may recover.
This study compares early versus standard liver transplant timing for people whose liver illness was caused by alcohol use. It looks at treatment outcomes to see which approach helps patients do better.
This early-phase study is testing a treatment approach for people with alcoholic hepatitis (liver inflammation caused by heavy alcohol use). It may help by improving liver function and outcomes in people who meet specific lab and health criteria.
This trial looks at the gut bacteria (microbiome) in people with severe alcoholic hepatitis to understand how it affects the illness. It may help doctors find better ways to treat this condition.
This trial tests whether fecal microbiota transplantation (a controlled transfer of stool bacteria) is safe in people with severe alcoholic hepatitis. It aims to see if the treatment is tolerable and what risks may come with it, in addition to watching how liver illness changes.
Hear when a new Alcohol-Related Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.